The GEO Group Inc
GEO
CoreCivic, Inc.
CXW
UnitedHealth
UNH
Eli Lilly and Co
LLY
Tractor Supply
TSCO
US Stock MarketDetailed Quotes
ASND Ascendis Pharma A/S
- 134.430
- -2.860-2.08%
Close Jan 8 16:00 ET
- 134.430
- 0.0000.00%
Post 20:01 ET
8.04BMarket Cap-17.46P/E (TTM)
138.650High133.820Low500.34KVolume136.480Open137.290Pre Close67.85MTurnover0.84%Turnover RatioLossP/E (Static)59.81MShares161.00052wk High-80.07P/B7.98BFloat Cap111.09052wk Low--Dividend TTM59.37MShs Float183.980Historical High--Div YieldTTM3.52%Amplitude11.920Historical Low135.601Avg Price1Lot Size
Ascendis Pharma A/S News
Ascendis Pharma Initiated at Buy by UBS
Ascendis Pharma Analyst Ratings
UBS Initiates Ascendis Pharma A/S(ASND.US) With Buy Rating, Announces Target Price $196
BofA Securities Maintains Ascendis Pharma A/S(ASND.US) With Buy Rating, Maintains Target Price $203
Morgan Stanley Maintains Ascendis Pharma A/S(ASND.US) With Hold Rating, Maintains Target Price $167
Morgan Stanley Maintains Ascendis Pharma A/S(ASND.US) With Hold Rating, Maintains Target Price $167
Morgan Stanley Maintains Ascendis Pharma A/S(ASND.US) With Hold Rating, Maintains Target Price $167
Morgan Stanley Maintains Ascendis Pharma A/S(ASND.US) With Hold Rating, Maintains Target Price $167
Evercore Maintains Ascendis Pharma A/S(ASND.US) With Buy Rating, Raises Target Price to $220
Jefferies Maintains Ascendis Pharma A/S(ASND.US) With Buy Rating, Maintains Target Price $194
A Quick Look at Today's Ratings for Ascendis Pharma A/S(ASND.US), With a Forecast Between $167 to $211
Ascendis Pharma (ASND) Gets a Buy From Stifel Nicolaus
Morgan Stanley Maintains Ascendis Pharma A/S(ASND.US) With Hold Rating, Maintains Target Price $167
Morgan Stanley Maintains Ascendis Pharma A/S(ASND.US) With Hold Rating, Maintains Target Price $167
Morgan Stanley Maintains Ascendis Pharma A/S(ASND.US) With Hold Rating, Maintains Target Price $167
Morgan Stanley Maintains Ascendis Pharma A/S(ASND.US) With Hold Rating, Maintains Target Price $167
A Quick Look at Today's Ratings for Ascendis Pharma A/S(ASND.US), With a Forecast Between $153 to $207
Ascendis Pharma Price Target Maintained With a $170.00/Share by Cantor Fitzgerald
Oppenheimer Adjusts Ascendis Pharma A/S Price Target to $180 From $190, Maintains Outperform Rating
Ascendis Pharma Is Maintained at Buy by Stifel
Trending US Stocks
Donald Trump Donald Trump
Trump-Election Stocks refer to securities closely associated with business dealings, political actions, or events related to Donald Trump. Trump-Election Stocks refer to securities closely associated with business dealings, political actions, or events related to Donald Trump.